-
Its success is associated with the rise of generic medication.
ECONOMIST: Pharmaceuticals in South Africa
-
Total revenues increased 10% year over year excluding the impact of Adderall whose sales dropped 32% when a generic version of the ADD medication was approved in the second quarter 2012.
FORBES: John Paulson's 4 Stocks Trading at 52-Week Lows
-
The tax applies to prescription medication companies, not generic drug producers.
FORBES: Remedy For Cash-Strapped State Courts: A Litigation Excise Tax
-
For Lilly, the day of reckoning was Oct. 25, 2011, when competitors announced a generic version of Zyprexa, an antipsychotic medication.
FORBES: Connect
-
Bristol-Myers Squibb has been hurt by competition from generic substitutes for proprietary drugs like Glucophage (diabetes medication), Taxol (cancer treatment) and BuSpar (antidepressant).
FORBES: Magazine Article
-
Mutual, however, argues that federal law preempts this type of claim, because the FDA had already approved its drug and federal law also requires a generic drug to have the same design as the brand-name medication ( here is the petition).
FORBES: Good For Generic Drugmakers? White House To Argue In Favor Of Preemption
-
The generic drug company had accused Bristol of illegally attempting to extend its patent on BuSpar, an anti-anxiety medication.
FORBES: Magazine Article